Rebeccamycin is a weak topoisomerase I inhibitor isolated from Streptomyces sp. It is structurally similar to staurosporine but does not show any inhibitory activity against protein kinases. It shows significant antitumor properties in vitro (IC50=480nM against mouse B16 melanoma cells and IC50=500nM against P388 leukemia cells).
This page contains content from the copyrighted Wikipedia article "Rebeccamycin"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
